EVO-NANO
Nanoparticle design platform to create evolving solutions for cancer treatment
We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform capable of autonomously evolving solutions for cancer treatment.
EVO-NANO brings together expertise in computer science, artificial evolution, modelling, microfluidics, and medicine.
We are a cross-disciplinary team working across Europe to produce targeted nanoparticles for the treatment of cancer tumours. Our scientists come from the University of Bristol and University of West of England, both in UK, University of Novi Sad, Serbia, Åbo Akademi University, Finland, IMDEA Software Institute, Vall d’Hebron Research Institute (VHIR), both in Spain, and ProChimia Surfaces in Poland.
Dec 23, appears to no longer exist. Website was https://evonano.eu/
Details last updated 03-Oct-2021
EVO-NANO News
EVONANO platform makes virtual tumour growth and drug design possible
University of Bristol - 22-Sep-2021
AI-powered software can be an alternative for expensive and extensive lab work
Read more...Technology to create virtual tumours and treat them with AI-designed nanoparticles
Nano Magazine - 22-Sep-2021
Virtual cancer tumours can be grown and we can design personalised nanoparticles to treat them
Read more...